FLT3 (FLK2 or STK1 or CD135) Antibody - FFPE Validated

About the Target

To connect mechanism with measurement, this antibody lets you explore FLT3 in pathway-driven studies. FLT3 is a signaling protein that can relay information through phosphorylation and complex assembly. Many projects interpret this target alongside interacting partners, upstream cues, and downstream readouts.

In some datasets and protocols, it is referenced by the gene symbol FLK2.

Research Context

Parallel measurement of upstream inputs and downstream readouts can sharpen interpretation of pathway behavior. Considering complex membership and compartment shifts can clarify whether changes reflect signaling or redistribution.

Consider these angles when interpreting target-level changes:

• time-resolved changes following stimulation or inhibition
• localization shifts between cytoplasm, membrane, and nucleus
• interaction patterns within multi-protein complexes

Variant Considerations

This fixed-section oriented version is intended for paraffin-embedded tissue, where crosslinking and retrieval steps can shape epitope accessibility. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

For challenging targets, pairing FLT3 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

If your study spans multiple model systems, it can help to define a shared reference condition for FLT3 so cross-sample contrasts stay meaningful.

Use the fixed-section version to relate FLT3 behavior to upstream cues and downstream consequences.